StockData
Health In Tech, Inc. logo

Health In Tech, Inc. (HIT) stock

HITNasdaqInsurance Agents, Brokers & ServiceFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 3/30
$0.38+0.05 (+15.71%)

Close on Nov 17, 2026Market cap $25.01MP/E –Yield –

Health In Tech r&d expenses

Research and development expenses are spending on new products and technology.

Health In Tech's R&D Expenses for the twelve months ending Jun 30, 2026 was $2.25M, down 9.2% year over year. For fiscal 2025 it was $1.57M, down 44.2% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.57M-44.2%
FY2024Dec 31, 2024$2.81M+40.4%
FY2023Dec 31, 2023$2.00M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$875.81K+50.3%
Q1 FY2026Mar 31, 2026$920.40K+71.2%
Q4 FY2025Dec 31, 2025$213.11K-66.4%
Q3 FY2025Sep 30, 2025$235.82K-67.2%
Q2 FY2025Jun 30, 2025$582.61K-17.0%
Q1 FY2025Mar 31, 2025$537.72K-29.3%
Q4 FY2024Dec 31, 2024$633.65K–
Q3 FY2024Sep 30, 2024$718.42K–
Q2 FY2024Jun 30, 2024$701.63K–
Q1 FY2024Mar 31, 2024$760.20K–

More Health In Tech figures

See a number that looks wrong?